

NurExone unit Exo-Top signed an MOU with ExoLyra for exclusive Mexico distribution rights for exosome products.
You can purchase shares of NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC (OTCQB:NRXBF) through any online brokerage.
There are no as such competitors for NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC.
There is no analysis for NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC to provide a consensus price target.
The stock price for NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC (OTCQB: NRXBF) is $0.33 last updated November 20, 2026 at 11:56 AM EST.
There are no upcoming dividends for NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC.
NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC does not have any upcoming earnings scheduled.
There is no upcoming split for NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC.
NUREXONE BIOLOGIC INC by NUREXONE BIOLOGIC INC is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.
NurExone Biologic Inc is a company that focuses on developing biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Its primary product is ExoTherapy, which is an exosome therapy production platform. It is...